Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. Tridello, G.
  4. Schwartz, J.
  5. Martinez-Cibrián, N.
  6. Barba, P.
  7. Kwon, M.
  8. Lopez-Corral, L.
  9. Martinez-Lopez, J.
  10. Ferra, C.
  11. Di Blasi, R.
  12. Ghesquieres, H.
  13. Mutsaers, P.
  14. Calkoen, F.
  15. Jak, M.
  16. van Doesum, J.
  17. Vermaat, J.S.P.
  18. van der Poel, M.
  19. Maertens, J.
  20. Gambella, M.
  21. Metafuni, E.
  22. Ciceri, F.
  23. Saccardi, R.
  24. Nicholson, E.
  25. Tholouli, E.
  26. Matthew, C.
  27. Potter, V.
  28. Bloor, A.
  29. Besley, C.
  30. Roddie, C.
  31. Wilson, K.
  32. Nagler, A.
  33. Campos, A.
  34. Petersen, S.L.
  35. Folber, F.
  36. Bader, P.
  37. Finke, J.
  38. Kroger, N.
  39. Knelange, N.
  40. de La Camara, R.
  41. Kersten, M.J.
  42. Mielke, S.
  43. Mostra tots els autors/es +
Revista:
Leukemia

ISSN: 1476-5551,  0887-6924

Any de publicació: 2024

Volum: 38

Número: 9

Pàgines: 1985-1991

Tipus: Article

DOI: 10.1038/S41375-024-02336-1 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus